Skip to main content

Series A Biotechnology Companies

Explore 774 biotechnology startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
774
Total Funding
$883.0M
Avg Funding
$35.3M
Cities
18

Export 774 Series A Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Paris, France
$11.6M
raised

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

Ithaca, United States
$12.0M
raised

Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$70.0M
raised

Excellergy develops immunology-based therapies focused on treating allergic diseases through novel biologic drug candidates.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

Seattle, United States
$10.0M
raised

Singletto develops novel antimicrobial solutions and singlet oxygen technology to protect against pathogens.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

New York, United States
$101.0M
raised

NILO Therapeutics is a biotechnology and therapeutics company.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Paris, France
$29.0M
raised

Phagos develops personalised bacteriophage solutions as a sustainable alternative to antibiotics

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

Barcelona, Spain
$14.1M
raised

Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

Berkeley, United States
$6.5M
raised

Bettani creates plant-based ingredients and products using data-driven technology and culinary expertise.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

Milan, Italy
$97.8M
raised

NanoPhoria develops non-viral, nano-delivery systems for cardiovascular treatments, focusing on inhalable biologics.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

Edinburgh, United Kingdom
$94.1M
raised

Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$23.4M
raised

Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for hematological diseases.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

New York, United States
$38.0M
raised

Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Vandoeuvre-lès-nancy, France
$12.5M
raised

StemInov develops stem cell therapies for inflammatory diseases, focusing on septic shock and ARDS.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Charlestown, United States
$7.0M
raised

Arkea Bio develops technology to cut greenhouse gas (GHG) emissions from the agricultural industry.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

New York, United States
$30.1M
raised

Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$25.0M
raised

VedaBio innovative platform for near-instant molecular detection.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$58.0M
raised

Until Labs is advancing technology to pause biological time, with a dedicated in-house team of biologists, engineers, and physicists.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Paris, France
$45.0M
raised

Plant-based Mining Biotech

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom
$5.4M
raised

Enhanc3D Genomics is a functional genomics company exploring the 3D organization of DNA in health and disease.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Boston, United States
$50.0M
raised

AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Toulouse, France
$5.4M
raised

Genoskin is a biotech company that leverages its expertise in skin biology and immunology to enhance the development of medications.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$65.0M
raised

Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

New York, United States
$50.0M
raised

Conceivable Life Sciences is an AI automation company that offers an automated IVF lab for cell therapies.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Marseille, France
$14.1M
raised

Tafalgie Therapeutics is a CNRS and AMU spin-off company engaged in biopharmaceutical research.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Vestavia Hills, United States
$8.0M
raised

ResBiotic develops probiotic and pharmabiotic therapies to alleviate neutrophilic inflammation associated with dysbiosis.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Showing 176 to 200 of 774 companies

Ready to Connect with Series A Biotechnology Startups?

Get verified founder emails, funding details, and company data for 774 series a biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

774 Biotechnology Series A Startups (November 2026) — Page 8 | VCBacked